New research has revealed the alarming prevalence and impact of back, neck and shoulder pain on the UK population. The survey, which polled 2,000 people across the country, found that almost three ...
A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...
The harrowing final messages of 25-year-old DJ Alex Theodossiadis before he died from meningitis have been revealed by his ...
The US Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows ...
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...